Stock LAM IND
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News LAM IND Other OTC

Equities

US51280R1041

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for LAM IND
2021 Parallel Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021 CI
2019 Easton Pharmaceuticals Inc. cancelled the acquisition of Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada. CI

All News

Search
See the results
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
AQ
EASTON PHARMACEUTICALS INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
AQ
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Parallel Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021
CI
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
EASTON PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Easton Pharmaceuticals Inc. cancelled the acquisition of Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada.
CI
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
GL
Easton Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
Easton Pharmaceuticals Inc. Moves its Corporate Head Office
CI
Easton Pharmaceuticals Inc. acquired Supreme Sweets Inc. from Barbara and Mario Parravano.
CI
Easton Pharmaceuticals Inc. Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division
CI
Easton Pharmaceuticals Inc. Commences Cannabis Edibles Division
CI
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
GL
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
GL
Easton Pharmaceuticals Inc. Announces Updates on its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
CI
Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018
GL
Easton Pharmaceuticals Inc. Announces Sales Results for the Quarter Ended September 30, 2018 and December 31, 2018
CI
Easton Pharmaceuticals Inc. Provides Operational Update on CAD 2,600,000 Framing Contract
CI
Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including New Additional Project
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EAPH Stock
  4. Stock
  5. News LAM IND